Location History:
- Chianti, IT (2016)
- Castellina, IT (2018 - 2020)
- Siena, IT (2018 - 2024)
Company Filing History:
Years Active: 2016-2024
Title: The Innovative Contributions of Allan James Saul
Introduction
Allan James Saul is a prominent inventor based in Castellina, Italy. He has made significant contributions to the field of immunology through his innovative work on conjugated antigens. With a total of 8 patents to his name, Saul's inventions are paving the way for advancements in immunogenic compositions and vaccination processes.
Latest Patents
Saul's latest patents include groundbreaking technologies such as "Immunogenic conjugates and use thereof." This technology focuses on conjugating native, non-detergent extracted outer membrane vesicles (nOMV) to antigens, forming nOMV-antigen conjugates that are particularly useful for immunogenic compositions and immunization. Additionally, he has developed "Multi-functionalized nOMV conjugates," which involve conjugating nOMV to multiple antigens, creating multifunctionalized nOMV-antigen conjugated derivatives that enhance immunogenic applications.
Career Highlights
Allan James Saul is currently associated with GlaxoSmithKline Biologicals SA, where he continues to innovate and contribute to the field of immunology. His work is characterized by a commitment to improving vaccine efficacy and safety through advanced conjugation techniques.
Collaborations
Saul collaborates with esteemed colleagues such as Francesca Micoli and Christiane Gerke, who share his dedication to advancing immunological research and development.
Conclusion
Allan James Saul's contributions to the field of immunology through his patents and collaborative efforts highlight his role as a leading inventor. His innovative approaches to conjugated antigens are set to make a lasting impact on vaccine development and immunization strategies.